Transient Intermittent Hyperglycemia Accelerates Atherosclerosis by Promoting Myelopoiesis

RATIONALE: Treatment efficacy for diabetes is largely determined by assessment of HbA1c levels, which poorly reflects direct glucose variation. People with pre-diabetes and diabetes spend >50% of their time outside the optimal glucose range. These glucose variations, termed transient intermittent...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Circ Res
Auteurs principaux: Flynn, Michelle C, Kraakman, Michael J, Tikellis, Christos, Lee, Man KS, Hanssen, Nordin MJ, Kammoun, Helene L, Pickering, Raelene J, Dragoljevic, Dragana, Al-Sharea, Annas, Barrett, Tessa J, Hortle, Fiona, Byrne, Frances L, Olzomer, Ellen, McCarthy, Domenica A, Schalkwijk, Casper G, Forbes, Josephine M, Hoehn, Kyle, Makowski, Liza, Lancaster, Graeme I, El-Osta, Assam, Fisher, Edward A, Goldberg, Ira J, Cooper, Mark E, Nagareddy, Prabhakara R, Thomas, Merlin C, Murphy, Andrew J
Format: Artigo
Langue:Inglês
Publié: 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7486277/
https://ncbi.nlm.nih.gov/pubmed/32564710
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCRESAHA.120.316653
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires